Follicular Lymphoma

• Follicular Lymphoma is a slow-growing non-Hodgkin lymphoma affecting B-cells.
• It often presents with few or no symptoms, leading to diagnosis during routine exams.
• Treatment strategies range from “watch and wait” to chemotherapy, immunotherapy, or radiation, depending on disease stage and patient factors.
• While generally incurable, it is highly treatable, and many patients live for many years.
• Regular monitoring is crucial due to its relapsing and remitting nature.

What is Follicular Lymphoma?

Follicular Lymphoma is a type of non-Hodgkin lymphoma (NHL) that develops from B-lymphocytes, a type of white blood cell crucial for the immune system. It is characterized by the abnormal growth of these cells, which typically cluster in a follicular or nodular pattern within lymph nodes, bone marrow, spleen, and sometimes other organs. This lymphoma is considered indolent, meaning it usually grows slowly over many years, often without causing immediate severe symptoms. It is one of the most common types of indolent NHL, accounting for approximately 20-30% of all NHL cases in Western countries. (Source: American Cancer Society).

Unlike more aggressive lymphomas, follicular lymphoma often follows a waxing and waning course, sometimes remaining stable for extended periods before progressing. It can affect people of any age but is more commonly diagnosed in older adults, with a median age of diagnosis around 60 years. While the exact cause of follicular lymphoma is not fully understood, it is believed to involve specific genetic mutations, particularly a translocation between chromosomes 14 and 18, which leads to the overexpression of the BCL2 gene. This gene helps prevent programmed cell death, contributing to the uncontrolled proliferation and survival of B-cells. Understanding what is follicular lymphoma involves recognizing its slow-growing nature and its origin from specific immune cells.

Symptoms and Diagnosis of Follicular Lymphoma

Many individuals with follicular lymphoma symptoms may experience none at all, especially in the early stages. The disease is often discovered incidentally during a routine physical examination or imaging scan for an unrelated condition. When symptoms do occur, they are typically non-specific and can include:

• Painless swelling of lymph nodes in the neck, armpit, or groin, which may fluctuate in size.
• Persistent fatigue that is not relieved by rest.
• Unexplained weight loss of more than 10% of body weight over six months.
• Recurrent fevers without an obvious infection.
• Drenching night sweats.

These “B symptoms” (fever, night sweats, weight loss) are important indicators of disease activity. Diagnosis of follicular lymphoma typically involves a biopsy of an affected lymph node. This procedure allows pathologists to examine the tissue under a microscope and perform specialized tests, such as immunohistochemistry and flow cytometry, to confirm the presence of follicular lymphoma cells and differentiate it from other types of lymphoma. Further staging tests, including bone marrow biopsy, CT scans of the chest, abdomen, and pelvis, and PET scans, are performed to determine the extent of the disease throughout the body and guide treatment decisions. Blood tests are also conducted to assess overall health and organ function.

Follicular Lymphoma Treatment and Prognosis

The approach to follicular lymphoma treatment options is highly individualized, depending on the disease stage, the presence of symptoms, the rate of growth, and the patient’s overall health. For many patients with asymptomatic, low-stage disease, a “watch and wait” strategy is often employed. This involves closely monitoring the patient without immediate active treatment, as early treatment has not been shown to improve overall survival in these cases.

When treatment is necessary, options may include chemotherapy, often combined with immunotherapy (e.g., rituximab, which targets the CD20 protein on lymphoma cells). Radiation therapy may be used for localized disease or to alleviate symptoms. Newer targeted therapies that interfere with specific pathways involved in cancer growth are also available. For patients with relapsed or refractory disease, stem cell transplantation may be considered.

The follicular lymphoma prognosis is generally favorable compared to more aggressive lymphomas, with many patients living for many years after diagnosis. It is often considered an incurable but highly treatable disease, meaning it can be managed effectively for long periods, even if it cannot be completely eradicated. However, follicular lymphoma can relapse, and some cases may transform into a more aggressive form of lymphoma. Regular follow-up and monitoring are essential to manage potential relapses or transformations. It is important to note that information about complementary therapies is supportive only and does not replace conventional medical treatment.